Dynavax Technologies Corporation
DVAX
$10.31
-$0.34-3.19%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 39.09% | 27.32% | 24.36% | 10.11% | -71.96% |
| Total Other Revenue | -78.29% | -82.14% | -5.30% | -15.23% | 95.32% |
| Total Revenue | 29.56% | 15.99% | 22.48% | 8.24% | -69.87% |
| Cost of Revenue | 42.67% | 0.29% | 1.28% | -14.42% | -48.96% |
| Gross Profit | 20.99% | 25.80% | 38.52% | 41.22% | -76.23% |
| SG&A Expenses | -0.04% | 13.25% | 12.32% | -2.94% | 29.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.08% | 7.79% | 7.67% | -7.16% | -16.01% |
| Operating Income | 108.83% | 101.13% | 624.29% | 32.39% | -105.88% |
| Income Before Tax | 665.96% | 40.10% | 254.31% | 51.52% | -98.53% |
| Income Tax Expenses | -25.48% | 1,612.93% | 353.61% | -550.65% | 222.41% |
| Earnings from Continuing Operations | 3,119.18% | 23.10% | 231.86% | 64.16% | -99.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3,119.18% | 23.10% | 231.86% | 64.16% | -99.68% |
| EBIT | 108.83% | 101.13% | 624.29% | 32.39% | -105.88% |
| EBITDA | 132.65% | 86.48% | 2,836.54% | 33.98% | -104.83% |
| EPS Basic | 3,141.18% | 21.12% | 225.84% | 64.77% | -99.68% |
| Normalized Basic EPS | 677.08% | 48.35% | 249.02% | 52.37% | -99.14% |
| EPS Diluted | 43,400.00% | 20.81% | 207.12% | 63.20% | -100.02% |
| Normalized Diluted EPS | 563.83% | 50.09% | 248.55% | 52.37% | -98.99% |
| Average Basic Shares Outstanding | -1.10% | 1.66% | 1.78% | 1.78% | 1.40% |
| Average Diluted Shares Outstanding | 14.81% | 0.40% | 1.53% | 1.78% | -12.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |